Found 6 matching trials
Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment PHASE2 Aerosol Combination therapy of All-trans retinoic acid and Isotretinoin as ...
Show More Location
Multiple Locations
Learn More & Join Trial
MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation PHASE1 The purpose of this study is evaluate the safety and tolerability of MPH966...
Show More Location
Duke University Adult Bone Marrow Transplant Clinic
Learn More & Join Trial
A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. PHASE2 The purpose of this study is to investigate the effect of alvelestat (an or...
Show More Location
University of Alabama, Birmingham (UAB)
Learn More & Join Trial
COVID-19 Study of Safety and Tolerability of Alvelestat PHASE1 The purpose of this study is to determine the safety, tolerability and phar...
Show More Location
UAB Lung Health Center
Learn More & Join Trial
Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation PHASE1 Background:
Bronchiolitis obliterans syndrome (BOS) is a complication peop...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency PHASE2 This is a Phase 2, multicenter, double-blind, randomized (1:1), placebo-con...
Show More Location
The University of Alabama at Birmingham Lung Health Center
Learn More & Join Trial